The medical technology company Resitu Medical AB, working with an innovative solution for tumor biopsies, announced today that Almi Invest, Stockholm Business Angels (STOAF) and private investors have invested €750 000 in the company. The investment will be used to initiate a development project aiming for CE marking in 2023. An additional SEK 20 million will be raised through equity.
42 startups from across Europe with 6 based in Scandinavia have been selected for the EIT Health Catapult semi-finals with an €210 000 investment prize fund and the Audience Award Winner displayed on the New York Nasdaq Tower.
The largest life science initiative world-wide, the European Network EIT Health, is now expanding its network to Finland as Helsinki University Hospital joins EIT Health Scandinavia. This means that the EU's top three most innovative regions including Stockholm, Sweden and Hovedstaden, Denmark are all part of the network.
Six European startups in biotech, medtech and digital health receive in total €180 000 in funding to access samples and collaborate with European biobanks and quality registers. During a year the companies will participate in an innovation program, Digital Sandbox funded by EIT Health.
Scandinavian startups selected for the 2020 annual EIT Health Headstart programme receiving in total up to €700 000 in funding 89 startups from across Europe of which 14 are based in Scandinavia are selected for support to accelerate the development of promising health solutions.
The COVID-19 pandemic is having a devastating impact on our society. As Europe’s largest organisation for collaboration within life science innovation, leveraging the strength of Europe’s leading health innovators, the EIT Health community wants to use its large network to play a role in responding to the crisis. We have therefore launched a COVID-19 response platform, facilitating connections bet
Ten SMEs have been selected to be funded and to participate in the EIT Health Digital Sandbox Programme. Chosen from around 30 applicants, the winners come from all over Europe and will receive funding and support that will help them in the development of relevant products and services through the involvement of, and collaboration with biobanks, sample holders and health registers in Europe.
The six best Scandinavian biotech, medtech and digital health start-ups have been selected by EIT Health Scandinavia for the EIT Health European Health Catapult semifinals (more information here). They will now compete with 36 other start-ups from other European regions for a place at the finals at the EIT Health Summit in Paris in December.
Imagine you are a small start-up, and you get the chance to meet 23 European incubators and R&D clusters who want to support your company’s international expansion! That was the envious situation of the start-up CEO:s participating in the final match-making meeting of the Bridgehead programme, held in Stockholm at Karolinska Institute campus on 18-19 June.
13 start-ups from all over Scandinavia have been granted the 2019 EIT Health Headstart funding. The start-ups were selected from around 50 applicants. The funding will allow the start-ups to take steps towards market launch and commercialization.
Welcome to a new way of learning: Co-Up Lab is new educational concept within the health context. It combines a physical creative space for co-creation of innovation with an educational programme for incubation of ideas. The Co-up lab is a mobile educational space that by “poping up” is utilising remote locations, taking health care education to end-users.
Joining French SME Aenitis as a guest of EIT Health at the meeting in Dublin
The Estonian SME Self-diagnostics was one of two particularly promising European start-ups that EIT Health chose to invite to the Medtech Strategist Forum, which unites more than 450 leading key decision-makers and investors in Dublin, Ireland during 9-11 April 2019.
SelfDiagnostics is a medtech company, headqua